Avadel Pharmaceuticals PLC

AVDL

NASDAQ. Currency in USD

8.49 -0.11 ( -1.28% )

Real time prices: December 09

Market Cap.
524.50M
Beta (5Y monthly)
1.62
Price/Earnings
-
EPS (TTM)
-1.66
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
278,200
1y Target Est.
12.25
Day's Range
8.45
-
8.79
52 Week's Range
1.05
-
10.02

Historical Summary

Performance
EPS growth
Share Buybacks

About Avadel Pharmaceuticals PLC

Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Website
https://www.avadel.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
59.03M
Employees
66
Address
10 Earlsfort Terrace, Dublin, Ireland, 2
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Latest news

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland, Dec. 01, 2022 (GLOBE NEWSWIRE) --  Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company...
By GlobeNewswire Inc. - 1 week ago

Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here...
By Benzinga - 1 week ago

Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022

Upgrades For Avadel Pharmaceuticals PLC (NASDAQ:AVDL), Jefferies upgraded the previous rating of Hold to Buy....
By Benzinga - 1 week ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

DUBLIN, Ireland, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical...
By GlobeNewswire Inc. - 2 weeks ago

Analyst Bumps Up Price Target For Avadel Pharmaceuticals After Favorable Patent Ruling
Analyst Bumps Up Price Target For Avadel Pharmaceuticals After Favorable Patent Ruling

Last Friday, Delaware District Court granted Avadel Pharmaceuticals plc's (NASDAQ: AVDL) motion to delist the...
By Benzinga - 2 weeks ago

Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday

Raymond James boosted The Procter & Gamble Company (NYSE: PG) price target from $155 to...
By Benzinga - 2 weeks ago

Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange Book
Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’s Orange Book

- Delisting of REMS Patent sets path to potentially accelerate final approval by FDA
By GlobeNewswire Inc. - 3 weeks ago

Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. Shares...
By Benzinga - 3 weeks ago